Summary: Researchers identified cortical gray matter thinning as a potential early biomarker for dementia. In a study involving 1,500 participants from diverse backgrounds, thinner cortical gray matter was linked to a higher risk of developing dementia 5 to 10 years before symptoms appeared.
This finding suggests that measuring gray matter thickness via MRI could be key in early dementia detection and intervention. The research highlights the importance of early diagnosis in managing and possibly slowing the progression of dementia.
Scientists have cleared a significant hurdle in the years-long effort to save Africa’s northern white rhinoceros from extinction with the first-ever rhino pregnancy using in vitro fertilization.
A new medical breakthrough with embryo transfer offers hope for Africa’s northern white rhinos—there are only two left.
People with long COVID have dysfunctional immune cells that show signs of chronic inflammation and faulty movement into organs, among other unusual activity, according to a new study by scientists at Gladstone Institutes and UC San Francisco (UCSF).
The team analyzed immune cells and hundreds of different immune molecules in the blood of 43 people with and without long COVID. They delved particularly deep into the characteristics of each person’s T cells—immune cells that help fight viral infections but can also trigger chronic inflammatory diseases.
Their findings, which appear in Nature Immunology, support the hypothesis that long COVID may involve a low-level viral persistence. The study also reveals a mismatch between the activity of T cells and other components of the immune system in people with long-term COVID-19.
In a recent study published in JAMA Neurology a group of researchers determined the utility of a novel and commercially available immunoassay for plasma phosphorylated tau 217 (p-tau217) to detect Alzheimer’s Disease (AD) pathology and evaluate reference ranges for abnormal amyloid β (Aβ) and longitudinal change across three selected cohorts.
Blood biomarkers have become key in AD diagnosis, offering a more scalable option than cerebrospinal fluid (CSF) or positron emission tomography (PET) scans. They are particularly beneficial in settings with limited access to advanced testing, paving the way for early and precise diagnosis and better patient management. p-tau, especially p-tau at threonine 217 (p-tau217), stands out as a leading blood biomarker. It excels in differentiating AD from other conditions and detecting AD in mild cognitive impairment cases, often outperforming other tau biomarkers.
As the medical community moves towards anti-Aβ therapies for dementia, validated blood biomarkers like p-tau217 are crucial for guiding treatment. Further research is necessary to validate plasma p-tau217 across diverse memory clinic populations, addressing comorbidities to enhance its clinical utility for AD.
Advanced Science is a high-impact, interdisciplinary science journal covering materials science, physics, chemistry, medical and life sciences, and engineering.
Eleven astronauts and cosmonauts from around the world are living and working together aboard the International Space Station (ISS) today, January 22. The four Axiom Mission 3 (Ax-3) private astronauts met the seven Expedition 70 crew members on Saturday beginning two weeks of dual operations.
The Ax-3 crew spent the weekend getting familiar with space station systems and emergency procedures before starting Monday with a full schedule of science and media activities. Ax-3 Commander Michael López-Alegría joined Pilot Walter Villadei and studied how microgravity affects the biochemistry of neurodegenerative diseases such as Alzheimer’s to improve health on Earth and in space. The duo later inserted samples into a fluorescence microscope for a study seeking to prevent and predict cancer diseases to protect crews in space and humans on Earth.
Year 2018 Age related symptoms may be even more simple to reverse by recharging the mitochondria then eventually we can have genetically engineered mitochondria to run longer so the cycles of the human body could run indefinitely.
Singh, B., Schoeb, T.R., Bajpai, P. et al. Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function. Cell Death Dis9, 735 (2018). https://doi.org/10.1038/s41419-018-0765-9
With the insertion of a little math, Sandia National Laboratories researchers have shown that neuromorphic computers, which synthetically replicate the brain’s logic, can solve more complex problems than those posed by artificial intelligence and may even earn a place in high-performance computing.
The findings, detailed in a recent article in the journal Nature Electronics, show that neuromorphic simulations employing the statistical method called random walks can track X-rays passing through bone and soft tissue, disease passing through a population, information flowing through social networks and the movements of financial markets, among other uses, said Sandia theoretical neuroscientist and lead researcher James Bradley Aimone.
“Basically, we have shown that neuromorphic hardware can yield computational advantages relevant to many applications, not just artificial intelligence to which it’s obviously kin,” said Aimone. “Newly discovered applications range from radiation transport and molecular simulations to computational finance, biology modeling and particle physics.”
What if AI could tell us we have cancer before we show a single symptom? Steve Quake, head of science at the Chan Zuckerberg Initiative, explains how AI can revolutionize science.
Up next, Harvard professor debunks the biggest exercise myths ► • Harvard professor debunks the biggest…
AI can help us understand complex systems like our cells. better. The Chan Zuckerberg Initiative is committed to building one of the world’s biggest non-profit life science AI computing clusters to help build digital models of what goes wrong in cells when we get diseases like diabetes or cancer and more.
